465 related articles for article (PubMed ID: 30839392)
61. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
[TBL] [Abstract][Full Text] [Related]
62. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care.
Jones MP; Walker MM; Ford AC; Talley NJ
Aliment Pharmacol Ther; 2014 Aug; 40(4):382-91. PubMed ID: 24961872
[TBL] [Abstract][Full Text] [Related]
63. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review.
Park MI; Camilleri M
Neurogastroenterol Motil; 2006 Aug; 18(8):595-607. PubMed ID: 16918724
[TBL] [Abstract][Full Text] [Related]
64. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
[TBL] [Abstract][Full Text] [Related]
65. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
[TBL] [Abstract][Full Text] [Related]
66. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case-control study of 23471 primary care patients.
Ford AC; Talley NJ; Walker MM; Jones MP
Aliment Pharmacol Ther; 2014 Oct; 40(7):827-34. PubMed ID: 25131320
[TBL] [Abstract][Full Text] [Related]
67. Herbal Preparation STW 5 for Functional Gastrointestinal Disorders: Clinical Experience in Everyday Practice.
Lapina TL; Trukhmanov AS
Dig Dis; 2017; 35 Suppl 1():30-35. PubMed ID: 29421814
[TBL] [Abstract][Full Text] [Related]
68. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
[TBL] [Abstract][Full Text] [Related]
69. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators.
Martin-Viñas JJ; Quigley EM
J Dig Dis; 2016 Sep; 17(9):572-581. PubMed ID: 27426409
[TBL] [Abstract][Full Text] [Related]
70. Mast Cells in Irritable Bowel Syndrome: A Systematic Review.
Krammer L; Sowa AS; Lorentz A
J Gastrointestin Liver Dis; 2019 Dec; 28(4):463-472. PubMed ID: 31826052
[TBL] [Abstract][Full Text] [Related]
71. Functional dyspepsia and irritable bowel syndrome in teenagers: Internet survey.
Kumagai H; Yokoyama K; Imagawa T; Yamagata T
Pediatr Int; 2016 Aug; 58(8):714-20. PubMed ID: 26690554
[TBL] [Abstract][Full Text] [Related]
72. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
Schurman JV; Karazsia BT; Friesen CA
Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
[TBL] [Abstract][Full Text] [Related]
73. Endoscopic laser endomicroscopy and "leaky gut" in patients with functional gastrointestinal symptoms and food intolerance.
Frieling T; Gjini B; Melchior I; Euler P; Kreysel C; Kalde S; Krummen B; Kiesslich R; Hemmerlein B
Z Gastroenterol; 2023 Nov; 61(11):1465-1471. PubMed ID: 36417920
[TBL] [Abstract][Full Text] [Related]
74. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.
Perveen I; Rahman MM; Saha M; Rahman MM; Hasan MQ
Indian J Gastroenterol; 2014 May; 33(3):265-73. PubMed ID: 24664445
[TBL] [Abstract][Full Text] [Related]
75. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
Chuah KH; Beh KH; Mahamad Rappek NA; Mahadeva S
J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
[TBL] [Abstract][Full Text] [Related]
76. Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients.
Hughes PA; Moretta M; Lim A; Grasby DJ; Bird D; Brierley SM; Liebregts T; Adam B; Blackshaw LA; Holtmann G; Bampton P; Hoffmann P; Andrews JM; Zola H; Krumbiegel D
Brain Behav Immun; 2014 Nov; 42():191-203. PubMed ID: 25063707
[TBL] [Abstract][Full Text] [Related]
77. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.
Sundin J; Nordlander S; Eutamene H; Alquier-Bacquie V; Cartier C; Theodorou V; Le Nevé B; Törnblom H; Simrén M; Öhman L
Neurogastroenterol Motil; 2019 Nov; 31(11):e13701. PubMed ID: 31518490
[TBL] [Abstract][Full Text] [Related]
78. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
[TBL] [Abstract][Full Text] [Related]
79. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders?
Andresen V; Camilleri M; Kim HJ; Stephens DA; Carlson PJ; Talley NJ; Saito YA; Urrutia R; Zinsmeister AR
Gastroenterology; 2006 Jun; 130(7):1985-94. PubMed ID: 16762621
[TBL] [Abstract][Full Text] [Related]
80. Effectiveness of Menthacarin on symptoms of irritable bowel syndrome.
Madisch A; Miehlke S; Labenz J; Stracke B; Köhler S
Wien Med Wochenschr; 2019 Apr; 169(5-6):149-155. PubMed ID: 29728848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
